PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35625225-3	2022	Human umbilical vein cells (HUVECs), co-cultured with erythrocyte-depleted whole blood for up to 48 h, were activated with tumor necrosis factor-alpha (TNF-alpha) or lipopolysaccharide (LPS) to induce endothelial damage in the absence or presence of cefiderocol (concentrations of 10, 40 and 70 mg/L).	cefiderocol	250-261	tumor necrosis factor	Homo sapiens	123-150	
35625225-3	2022	Human umbilical vein cells (HUVECs), co-cultured with erythrocyte-depleted whole blood for up to 48 h, were activated with tumor necrosis factor-alpha (TNF-alpha) or lipopolysaccharide (LPS) to induce endothelial damage in the absence or presence of cefiderocol (concentrations of 10, 40 and 70 mg/L).	cefiderocol	250-261	tumor necrosis factor	Homo sapiens	152-161	
35625225-6	2022	Furthermore, cefiderocol reduces interleukin-6 (IL-6), interleukin-1beta (IL-1beta) and TNF-alpha release in peripheral blood mononuclear cells (PBMCs) following LPS stimulation in a dose-dependent manner.	cefiderocol	13-24	tumor necrosis factor	Homo sapiens	88-97